Identification of compounds that decrease glioblastoma growth and glucose uptake in vitro

Tumor heterogeneity has hampered the development of novel effective therapeutic options for aggressive cancers, including the deadly primary adult brain tumor glioblastoma (GBM). Intratumoral heterogeneity is partially attributed to the tumor initiating cell (TIC) subset that contains highly tumorig...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Chem Biol
Principais autores: Libby, Catherine J, Zhang, Sixue, Benavides, Gloria A., Scott, Sarah E, Li, Yanjie, Redmann, Matthew, Tran, Anh Nhat, Otamias, Arphaxad, Darley-Usmar, Victor, Napierala, Marek, Zhang, Jianhua, Augelli-Szafran, Corinne Elizabeth, Zhang, Wei, Hjelmeland, Anita B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6425477/
https://ncbi.nlm.nih.gov/pubmed/29905460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschembio.8b00251
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados